Share Price and Basic Stock Data
Last Updated: November 14, 2025, 8:43 am
| PEG Ratio | -1.07 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Cineline India Ltd operates in the entertainment and media industry, primarily engaging in film production and distribution. The company’s revenue trajectory has shown significant fluctuations over the years. In FY 2022, sales stood at ₹45 Cr, which rose to ₹141 Cr in FY 2023, indicating a substantial recovery phase post-pandemic. For FY 2024, sales are reported at ₹190 Cr, reflecting a continued upward trend. The quarterly sales figures also exhibit variability; for instance, sales peaked at ₹64 Cr in September 2023 but saw a decline to ₹52 Cr in December 2023. This inconsistency in quarterly performance may be attributed to seasonal variations in film releases and consumer demand. Additionally, the company reported a marked increase in sales from ₹15 Cr in March 2022 to ₹45 Cr in March 2023, indicating a robust growth phase. The overall market capitalization of Cineline India Ltd is ₹295 Cr, with a price-to-earnings ratio of 35.6, suggesting that investors are willing to pay a premium for its earnings potential amid these revenue fluctuations.
Profitability and Efficiency Metrics
Cineline India’s profitability metrics reveal a mixed performance. The operating profit margin (OPM) stood at 16% in its latest reporting, which, while decent, has shown variability over the past quarters, peaking at 31% in September 2023 before declining to 22% in December 2023. The net profit reported for FY 2023 was ₹2 Cr, a recovery from the losses of ₹7 Cr in FY 2022. However, the company has faced challenges, with a declining net profit margin of -8.36% in FY 2025, indicating a struggle to maintain profitability. The interest coverage ratio (ICR) stood at 1.47x, suggesting that the company can cover its interest obligations, albeit with some difficulty. The return on equity (ROE) is reported at 5.66%, which is relatively low compared to sector averages, indicating that the company may not be maximizing shareholder returns efficiently. Despite these challenges, Cineline’s operational metrics are improving, which could signal potential for future profitability if managed effectively.
Balance Sheet Strength and Financial Ratios
The financial health of Cineline India Ltd is marked by a balance sheet that shows both strengths and vulnerabilities. As of the latest reporting, total borrowings amounted to ₹106 Cr, a significant reduction from ₹354 Cr in FY 2023, suggesting a strategic effort to deleverage. The equity capital has remained stable at ₹17 Cr, while reserves reported stand at ₹126 Cr, indicating a reasonable buffer for future investments or contingencies. The company’s current ratio is noted at 1.13x, which is above the typical sector benchmark of 1.0, reflecting adequate liquidity to cover short-term obligations. However, a price-to-book value ratio of 1.95x indicates that the stock is trading at a premium relative to its book value, which could deter value-oriented investors. The return on capital employed (ROCE) reported at 4.75% is below the industry average, signaling inefficiencies in capital usage. Overall, while the balance sheet displays some positive signs of strengthening, the company still faces challenges in optimizing its capital structure.
Shareholding Pattern and Investor Confidence
Cineline India Ltd’s shareholding pattern indicates a strong promoter presence, with promoters holding 69.60% of the equity as of March 2025. This level of promoter ownership can be seen as a positive indicator of alignment with shareholder interests. However, foreign institutional investors (FIIs) hold a mere 1.41%, suggesting limited external confidence in the stock, which could reflect concerns over the company’s financial performance. The domestic institutional investors (DIIs) represent just 0.03%, indicating minimal institutional interest. The public shareholding stands at 28.96%, with the number of shareholders reported at 15,292, showing a relatively broad base of retail investors. The decline in the number of shareholders from 17,782 in September 2022 to 15,292 in March 2025 may raise concerns about investor confidence and market sentiment. The low levels of institutional ownership could affect the stock’s liquidity and overall market perception, potentially impacting future capital raising efforts.
Outlook, Risks, and Final Insight
The outlook for Cineline India Ltd hinges on its ability to capitalize on the growing demand for entertainment content while addressing its financial inefficiencies. The recent increase in sales suggests a recovering market, but the volatility in quarterly revenue highlights potential risks associated with consumer demand shifts and competition. Additionally, the company’s low profitability margins and high debt levels pose significant challenges that must be navigated to ensure long-term viability. The focus on reducing borrowings is a positive step, but it must be complemented by strategies to enhance operational efficiency and profitability. If Cineline can stabilize its earnings and improve investor confidence, it may attract more institutional interest, which is crucial for sustainable growth. Conversely, failure to address these financial and operational challenges could lead to further declines in profitability and shareholder sentiment, underscoring the need for strategic management decisions going forward.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Cineline India Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hathway Bhawani Cabletel & Datacom Ltd | 12.2 Cr. | 15.1 | 21.7/13.0 | 76.3 | 2.22 | 0.00 % | 3.38 % | 2.25 % | 10.0 |
| G V Films Ltd | 67.1 Cr. | 0.36 | 0.82/0.30 | 0.61 | 0.00 % | 2.36 % | 2.68 % | 1.00 | |
| Encash Entertainment Ltd | 11.3 Cr. | 29.0 | / | 20.8 | 0.00 % | 4.70 % | 4.70 % | 10.0 | |
| Diksat Transworld Ltd | 211 Cr. | 120 | 148/100 | 3,508 | 14.4 | 0.00 % | 2.82 % | 0.24 % | 10.0 |
| Cyber Media (India) Ltd | 27.1 Cr. | 17.3 | 30.1/11.0 | 28.2 | 5.43 | 0.00 % | 4.52 % | % | 10.0 |
| Industry Average | 2,352.65 Cr | 125.02 | 362.56 | 37.10 | 0.20% | 15.66% | 12.68% | 6.15 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 15 | 30 | 24 | 42 | 45 | 37 | 64 | 52 | 37 | 36 | 56 | 63 | 55 |
| Expenses | 9 | 22 | 22 | 33 | 39 | 31 | 44 | 41 | 33 | 33 | 42 | 49 | 46 |
| Operating Profit | 5 | 8 | 2 | 9 | 6 | 6 | 20 | 12 | 4 | 3 | 13 | 15 | 9 |
| OPM % | 36% | 25% | 7% | 21% | 14% | 16% | 31% | 22% | 12% | 9% | 24% | 23% | 16% |
| Other Income | 1 | -2 | 28 | 1 | 1 | 0 | -1 | 2 | 2 | -3 | 1 | 4 | -25 |
| Interest | 8 | 6 | 8 | 10 | 10 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Depreciation | 4 | 3 | 5 | 7 | 7 | 5 | 5 | 5 | 5 | 5 | 6 | 7 | 7 |
| Profit before tax | -5 | -4 | 17 | -6 | -10 | -6 | 6 | 2 | -7 | -13 | 1 | 5 | -31 |
| Tax % | 58% | -19% | 0% | -24% | -27% | -18% | 21% | 24% | -3% | -17% | 24% | 6% | -59% |
| Net Profit | -7 | -3 | 17 | -5 | -7 | -5 | 5 | 2 | -7 | -11 | 1 | 5 | -12 |
| EPS in Rs | -2.44 | -1.10 | 5.37 | -1.50 | -2.22 | -1.49 | 1.59 | 0.48 | -1.92 | -3.08 | 0.27 | 1.32 | -3.64 |
Last Updated: May 31, 2025, 9:31 am
Below is a detailed analysis of the quarterly data for Cineline India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 55.00 Cr.. The value appears to be declining and may need further review. It has decreased from 63.00 Cr. (Dec 2024) to 55.00 Cr., marking a decrease of 8.00 Cr..
- For Expenses, as of Mar 2025, the value is 46.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 49.00 Cr. (Dec 2024) to 46.00 Cr., marking a decrease of 3.00 Cr..
- For Operating Profit, as of Mar 2025, the value is 9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Dec 2024) to 9.00 Cr., marking a decrease of 6.00 Cr..
- For OPM %, as of Mar 2025, the value is 16.00%. The value appears to be declining and may need further review. It has decreased from 23.00% (Dec 2024) to 16.00%, marking a decrease of 7.00%.
- For Other Income, as of Mar 2025, the value is -25.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Dec 2024) to -25.00 Cr., marking a decrease of 29.00 Cr..
- For Interest, as of Mar 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 7.00 Cr..
- For Depreciation, as of Mar 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 7.00 Cr..
- For Profit before tax, as of Mar 2025, the value is -31.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.00 Cr. (Dec 2024) to -31.00 Cr., marking a decrease of 36.00 Cr..
- For Tax %, as of Mar 2025, the value is -59.00%. The value appears to be improving (decreasing) as expected. It has decreased from 6.00% (Dec 2024) to -59.00%, marking a decrease of 65.00%.
- For Net Profit, as of Mar 2025, the value is -12.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.00 Cr. (Dec 2024) to -12.00 Cr., marking a decrease of 17.00 Cr..
- For EPS in Rs, as of Mar 2025, the value is -3.64. The value appears to be declining and may need further review. It has decreased from 1.32 (Dec 2024) to -3.64, marking a decrease of 4.96.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:30 am
| Metric | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 102 | 159 | 192 | 192 | 286 | 24 | 26 | 29 | 45 | 141 | 190 | 211 |
| Expenses | 76 | 131 | 162 | 162 | 247 | 8 | 9 | 15 | 34 | 116 | 148 | 171 |
| Operating Profit | 26 | 28 | 31 | 30 | 39 | 16 | 17 | 13 | 11 | 25 | 41 | 40 |
| OPM % | 25% | 18% | 16% | 16% | 14% | 66% | 66% | 46% | 25% | 18% | 22% | 19% |
| Other Income | 5 | 13 | 1 | 6 | -4 | 11 | 17 | 25 | 5 | 27 | 3 | -24 |
| Interest | 3 | 6 | 8 | 11 | 15 | 10 | 18 | 22 | 35 | 34 | 29 | 29 |
| Depreciation | 7 | 19 | 17 | 19 | 21 | 4 | 5 | 8 | 19 | 22 | 20 | 24 |
| Profit before tax | 20 | 15 | 6 | 5 | -2 | 14 | 10 | 8 | -38 | -5 | -4 | -37 |
| Tax % | 32% | 27% | -164% | -8% | -260% | 27% | 21% | 37% | -6% | -138% | 11% | -53% |
| Net Profit | 14 | 11 | 17 | 5 | 4 | 10 | 8 | 5 | -35 | 2 | -5 | -18 |
| EPS in Rs | 3.52 | 2.72 | 1.71 | -11.78 | 0.55 | -1.32 | -5.14 | |||||
| Dividend Payout % | 31% | 30% | 20% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2008-2009 | 2009-2010 | 2010-2011 | 2011-2012 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -21.43% | 54.55% | -70.59% | -20.00% | -20.00% | -37.50% | -800.00% | 105.71% | -350.00% | -260.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 75.97% | -125.13% | 50.59% | 0.00% | -17.50% | -762.50% | 905.71% | -455.71% | 90.00% |
Cineline India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2008-2009 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 52% |
| 3 Years: | 67% |
| TTM: | -15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 3% |
| 3 Years: | 31% |
| TTM: | 288% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 24% |
| 3 Years: | -13% |
| 1 Year: | -28% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | -4% |
| 3 Years: | 1% |
| Last Year: | 6% |
Last Updated: September 5, 2025, 2:00 am
Balance Sheet
Last Updated: May 13, 2025, 3:41 pm
| Month | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 28 | 28 | 28 | 28 | 28 | 14 | 14 | 14 | 15 | 16 | 17 | 17 |
| Reserves | 120 | 125 | 138 | 143 | 147 | 100 | 108 | 113 | 94 | 123 | 132 | 126 |
| Borrowings | 97 | 82 | 88 | 98 | 125 | 158 | 171 | 322 | 322 | 354 | 350 | 106 |
| Other Liabilities | 40 | 61 | 45 | 73 | 76 | 16 | 32 | 19 | 18 | 86 | 78 | 65 |
| Total Liabilities | 285 | 295 | 298 | 342 | 375 | 288 | 325 | 468 | 449 | 580 | 577 | 314 |
| Fixed Assets | 161 | 194 | 208 | 217 | 243 | 231 | 104 | 391 | 361 | 485 | 479 | 215 |
| CWIP | 37 | 28 | 20 | 40 | 24 | 0 | 0 | 0 | 3 | 5 | 9 | 4 |
| Investments | 29 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 58 | 73 | 70 | 85 | 108 | 57 | 221 | 77 | 84 | 90 | 89 | 95 |
| Total Assets | 285 | 295 | 298 | 342 | 375 | 288 | 325 | 468 | 449 | 580 | 577 | 314 |
Below is a detailed analysis of the balance sheet data for Cineline India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 17.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 17.00 Cr..
- For Reserves, as of Mar 2025, the value is 126.00 Cr.. The value appears to be declining and may need further review. It has decreased from 132.00 Cr. (Mar 2024) to 126.00 Cr., marking a decrease of 6.00 Cr..
- For Borrowings, as of Mar 2025, the value is 106.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 350.00 Cr. (Mar 2024) to 106.00 Cr., marking a decrease of 244.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 65.00 Cr.. The value appears to be improving (decreasing). It has decreased from 78.00 Cr. (Mar 2024) to 65.00 Cr., marking a decrease of 13.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 314.00 Cr.. The value appears to be improving (decreasing). It has decreased from 577.00 Cr. (Mar 2024) to 314.00 Cr., marking a decrease of 263.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 215.00 Cr.. The value appears to be declining and may need further review. It has decreased from 479.00 Cr. (Mar 2024) to 215.00 Cr., marking a decrease of 264.00 Cr..
- For CWIP, as of Mar 2025, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Mar 2024) to 4.00 Cr., marking a decrease of 5.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 95.00 Cr.. The value appears strong and on an upward trend. It has increased from 89.00 Cr. (Mar 2024) to 95.00 Cr., marking an increase of 6.00 Cr..
- For Total Assets, as of Mar 2025, the value is 314.00 Cr.. The value appears to be declining and may need further review. It has decreased from 577.00 Cr. (Mar 2024) to 314.00 Cr., marking a decrease of 263.00 Cr..
Notably, the Reserves (126.00 Cr.) exceed the Borrowings (106.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -71.00 | -54.00 | -57.00 | -68.00 | -86.00 | -142.00 | -154.00 | -309.00 | -311.00 | -329.00 | -309.00 | -66.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 20 | 16 | 13 | 18 | 14 | 42 | 26 | 55 | 26 | 14 | 8 | 3 |
| Inventory Days | 17 | 26 | 54 | |||||||||
| Days Payable | 1,685 | 411 | 443 | |||||||||
| Cash Conversion Cycle | -1,648 | 16 | 13 | -367 | -375 | 42 | 26 | 55 | 26 | 14 | 8 | 3 |
| Working Capital Days | 56 | 36 | 40 | -119 | -52 | 385 | 70 | 37 | -95 | -182 | -60 | -46 |
| ROCE % | 11% | 8% | 8% | 6% | 8% | 10% | 8% | -1% | 1% | 8% | 5% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | -5.14 | -1.40 | 0.54 | -12.19 | 1.71 |
| Diluted EPS (Rs.) | -5.14 | -1.40 | 0.54 | -12.19 | 1.71 |
| Cash EPS (Rs.) | 1.99 | 7.67 | 7.44 | -5.39 | 4.54 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 41.80 | 43.62 | 44.02 | 36.21 | 45.28 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 41.80 | 43.62 | 44.02 | 36.21 | 45.28 |
| Revenue From Operations / Share (Rs.) | 61.47 | 72.32 | 44.53 | 14.95 | 10.20 |
| PBDIT / Share (Rs.) | 12.32 | 19.98 | 8.78 | 5.48 | 13.51 |
| PBIT / Share (Rs.) | 5.18 | 10.99 | 1.86 | -0.91 | 10.68 |
| PBT / Share (Rs.) | -10.75 | -1.09 | -8.89 | -12.54 | 2.73 |
| Net Profit / Share (Rs.) | -5.14 | -1.32 | 0.52 | -11.78 | 1.71 |
| NP After MI And SOA / Share (Rs.) | -5.14 | -1.32 | 0.52 | -11.78 | 1.71 |
| PBDIT Margin (%) | 20.04 | 27.62 | 19.71 | 36.63 | 132.40 |
| PBIT Margin (%) | 8.43 | 15.19 | 4.17 | -6.12 | 104.62 |
| PBT Margin (%) | -17.48 | -1.51 | -19.96 | -83.85 | 26.72 |
| Net Profit Margin (%) | -8.36 | -1.83 | 1.17 | -78.79 | 16.75 |
| NP After MI And SOA Margin (%) | -8.36 | -1.83 | 1.17 | -78.79 | 16.75 |
| Return on Networth / Equity (%) | -12.30 | -3.03 | 1.19 | -32.54 | 3.77 |
| Return on Capital Employeed (%) | 6.81 | 7.54 | 1.22 | -0.65 | 6.61 |
| Return On Assets (%) | -5.60 | -0.78 | 0.28 | -7.85 | 1.00 |
| Long Term Debt / Equity (X) | 0.00 | 1.46 | 1.60 | 2.80 | 2.45 |
| Total Debt / Equity (X) | 0.00 | 1.53 | 1.74 | 2.95 | 2.45 |
| Asset Turnover Ratio (%) | 0.47 | 0.42 | 0.27 | 0.03 | 0.05 |
| Current Ratio (X) | 1.13 | 0.63 | 0.55 | 1.55 | 1.69 |
| Quick Ratio (X) | 1.08 | 0.60 | 0.53 | 1.55 | 1.68 |
| Inventory Turnover Ratio (X) | 87.67 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 1.47 | 1.65 | 0.81 | 0.47 | 1.70 |
| Interest Coverage Ratio (Post Tax) (X) | 1.31 | 0.89 | 0.36 | -0.01 | 1.22 |
| Enterprise Value (Cr.) | 245.80 | 633.90 | 508.91 | 594.81 | 374.22 |
| EV / Net Operating Revenue (X) | 1.17 | 2.56 | 3.62 | 13.22 | 13.10 |
| EV / EBITDA (X) | 5.82 | 9.26 | 18.36 | 36.08 | 9.89 |
| MarketCap / Net Operating Revenue (X) | 1.32 | 1.68 | 2.08 | 6.72 | 3.08 |
| Price / BV (X) | 1.95 | 2.79 | 2.10 | 2.78 | 0.69 |
| Price / Net Operating Revenue (X) | 1.32 | 1.68 | 2.08 | 6.72 | 3.08 |
| EarningsYield | -0.06 | -0.01 | 0.01 | -0.11 | 0.05 |
After reviewing the key financial ratios for Cineline India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -5.14. This value is below the healthy minimum of 5. It has decreased from -1.40 (Mar 24) to -5.14, marking a decrease of 3.74.
- For Diluted EPS (Rs.), as of Mar 25, the value is -5.14. This value is below the healthy minimum of 5. It has decreased from -1.40 (Mar 24) to -5.14, marking a decrease of 3.74.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.99. This value is below the healthy minimum of 3. It has decreased from 7.67 (Mar 24) to 1.99, marking a decrease of 5.68.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 41.80. It has decreased from 43.62 (Mar 24) to 41.80, marking a decrease of 1.82.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 41.80. It has decreased from 43.62 (Mar 24) to 41.80, marking a decrease of 1.82.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 61.47. It has decreased from 72.32 (Mar 24) to 61.47, marking a decrease of 10.85.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 12.32. This value is within the healthy range. It has decreased from 19.98 (Mar 24) to 12.32, marking a decrease of 7.66.
- For PBIT / Share (Rs.), as of Mar 25, the value is 5.18. This value is within the healthy range. It has decreased from 10.99 (Mar 24) to 5.18, marking a decrease of 5.81.
- For PBT / Share (Rs.), as of Mar 25, the value is -10.75. This value is below the healthy minimum of 0. It has decreased from -1.09 (Mar 24) to -10.75, marking a decrease of 9.66.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -5.14. This value is below the healthy minimum of 2. It has decreased from -1.32 (Mar 24) to -5.14, marking a decrease of 3.82.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -5.14. This value is below the healthy minimum of 2. It has decreased from -1.32 (Mar 24) to -5.14, marking a decrease of 3.82.
- For PBDIT Margin (%), as of Mar 25, the value is 20.04. This value is within the healthy range. It has decreased from 27.62 (Mar 24) to 20.04, marking a decrease of 7.58.
- For PBIT Margin (%), as of Mar 25, the value is 8.43. This value is below the healthy minimum of 10. It has decreased from 15.19 (Mar 24) to 8.43, marking a decrease of 6.76.
- For PBT Margin (%), as of Mar 25, the value is -17.48. This value is below the healthy minimum of 10. It has decreased from -1.51 (Mar 24) to -17.48, marking a decrease of 15.97.
- For Net Profit Margin (%), as of Mar 25, the value is -8.36. This value is below the healthy minimum of 5. It has decreased from -1.83 (Mar 24) to -8.36, marking a decrease of 6.53.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -8.36. This value is below the healthy minimum of 8. It has decreased from -1.83 (Mar 24) to -8.36, marking a decrease of 6.53.
- For Return on Networth / Equity (%), as of Mar 25, the value is -12.30. This value is below the healthy minimum of 15. It has decreased from -3.03 (Mar 24) to -12.30, marking a decrease of 9.27.
- For Return on Capital Employeed (%), as of Mar 25, the value is 6.81. This value is below the healthy minimum of 10. It has decreased from 7.54 (Mar 24) to 6.81, marking a decrease of 0.73.
- For Return On Assets (%), as of Mar 25, the value is -5.60. This value is below the healthy minimum of 5. It has decreased from -0.78 (Mar 24) to -5.60, marking a decrease of 4.82.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 1.46 (Mar 24) to 0.00, marking a decrease of 1.46.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 1.53 (Mar 24) to 0.00, marking a decrease of 1.53.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.47. It has increased from 0.42 (Mar 24) to 0.47, marking an increase of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 1.13. This value is below the healthy minimum of 1.5. It has increased from 0.63 (Mar 24) to 1.13, marking an increase of 0.50.
- For Quick Ratio (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has increased from 0.60 (Mar 24) to 1.08, marking an increase of 0.48.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 87.67. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 87.67, marking an increase of 87.67.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.47. This value is below the healthy minimum of 3. It has decreased from 1.65 (Mar 24) to 1.47, marking a decrease of 0.18.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.31. This value is below the healthy minimum of 3. It has increased from 0.89 (Mar 24) to 1.31, marking an increase of 0.42.
- For Enterprise Value (Cr.), as of Mar 25, the value is 245.80. It has decreased from 633.90 (Mar 24) to 245.80, marking a decrease of 388.10.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.17. This value is within the healthy range. It has decreased from 2.56 (Mar 24) to 1.17, marking a decrease of 1.39.
- For EV / EBITDA (X), as of Mar 25, the value is 5.82. This value is within the healthy range. It has decreased from 9.26 (Mar 24) to 5.82, marking a decrease of 3.44.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.32. This value is within the healthy range. It has decreased from 1.68 (Mar 24) to 1.32, marking a decrease of 0.36.
- For Price / BV (X), as of Mar 25, the value is 1.95. This value is within the healthy range. It has decreased from 2.79 (Mar 24) to 1.95, marking a decrease of 0.84.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.32. This value is within the healthy range. It has decreased from 1.68 (Mar 24) to 1.32, marking a decrease of 0.36.
- For EarningsYield, as of Mar 25, the value is -0.06. This value is below the healthy minimum of 5. It has decreased from -0.01 (Mar 24) to -0.06, marking a decrease of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Cineline India Ltd:
- Net Profit Margin: -8.36%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 6.81% (Industry Average ROCE: 15.33%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -12.3% (Industry Average ROE: 10.52%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.31
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.08
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 36 (Industry average Stock P/E: 192.85)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -8.36%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Entertainment & Media | 2nd Floor, A & B wing, Vilco Centre, Mumbai Maharashtra 400057 | investor@cineline.co.in http://www.moviemax.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Rasesh B Kanakia | Chairman |
| Mr. Himanshu B Kanakia | Managing Director |
| Mrs. Hiral Kanakia | Director |
| Mr. Naushad Panjwani | Independent Director |
| Mr. Shantilal Vershi Haria | Independent Director |
| Mr. Sanjiv Mehta | Independent Director |
FAQ
What is the intrinsic value of Cineline India Ltd?
Cineline India Ltd's intrinsic value (as of 14 November 2025) is 69.50 which is 20.21% lower the current market price of 87.10, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 298 Cr. market cap, FY2025-2026 high/low of 150/73.6, reserves of ₹126 Cr, and liabilities of 314 Cr.
What is the Market Cap of Cineline India Ltd?
The Market Cap of Cineline India Ltd is 298 Cr..
What is the current Stock Price of Cineline India Ltd as on 14 November 2025?
The current stock price of Cineline India Ltd as on 14 November 2025 is 87.1.
What is the High / Low of Cineline India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Cineline India Ltd stocks is 150/73.6.
What is the Stock P/E of Cineline India Ltd?
The Stock P/E of Cineline India Ltd is 36.0.
What is the Book Value of Cineline India Ltd?
The Book Value of Cineline India Ltd is 41.8.
What is the Dividend Yield of Cineline India Ltd?
The Dividend Yield of Cineline India Ltd is 0.00 %.
What is the ROCE of Cineline India Ltd?
The ROCE of Cineline India Ltd is 4.75 %.
What is the ROE of Cineline India Ltd?
The ROE of Cineline India Ltd is 5.66 %.
What is the Face Value of Cineline India Ltd?
The Face Value of Cineline India Ltd is 5.00.